Biodexa Pharmaceuticals Plc - BDRX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GAMMA Investing LLC | History | Added to | 13,780 | 8 | 0.0% | 0.0% | 1 | +12,003 | 675.46% | Q1 2026 | Apr 06, 2026 |
| SABBY MANAGEMENT, LLC | History | Closed out | 0 | 0 | — | 0.62% | — | -190,658 | -100.0% | Q4 2025 | Feb 17, 2026 |
| ARMISTICE CAPITAL, LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -100,000 | -100.0% | Q4 2025 | Feb 17, 2026 |
| HRT FINANCIAL LP | History | Closed out | 0 | 0 | — | 0.0% | — | -10,583 | -100.0% | Q4 2025 | Feb 12, 2026 |
| UBS Group AG | History | Closed out | 0 | 0 | — | 0.0% | — | -2,100 | -100.0% | Q4 2025 | Jan 29, 2026 |
| SBI Securities Co., Ltd. | History | Closed out | 0 | 0 | — | — | — | -101 | -100.0% | Q4 2025 | Feb 03, 2026 |
| RHUMBLINE ADVISERS | History | Closed out | 0 | 0 | — | — | — | -24 | -100.0% | Q4 2025 | Feb 13, 2026 |
| Hilton Head Capital Partners, LLC | History | No change | 30 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | Apr 20, 2026 |